Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis

por Decroo, Tom, Aung, Kya Jai Maug, Hossain, Mohamed Anwar, Gumusboga, Mourad, Ortuno-Gutierrez, Nimer, De Jong, Bouke Catherine, Van Deun, Armand
Publicado 2022

Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings

por Van Deun, Armand, Bola, Valentin, Lebeke, Rossin, Kaswa, Michel, Hossain, Mohamed Anwar, Gumusboga, Mourad, Torrea, Gabriela, De Jong, Bouke Catharine, Rigouts, Leen, Decroo, Tom
Publicado 2022

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes

por Decroo, Tom, Maug, Aung Kya Jai, Hossain, Mohamed Anwar, Uwizeye, Cécile, Gumusboga, Mourad, Demeulenaere, Tine, Ortuño-Gutiérrez, Nimer, de Jong, Bouke C., Van Deun, Armand
Publicado 2020

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance

por Torrea, Gabriela, Ng, Kamela C. S., Van Deun, Armand, André, Emmanuel, Kaisergruber, Justine, Ssengooba, Willy, Desmaretz, Christel, Gabriels, Siemon, Driesen, Michèle, Diels, Maren, Asnong, Sylvie, Fissette, Kristina, Gumusboga, Mourad, Rigouts, Leen, Affolabi, Dissou, Joloba, Moses, De Jong, Bouke C.
Publicado 2019